secwatch.observer — SEC 8-K summary
======================================

Issuer:     CV Sciences, Inc. (CVSI)
CIK:        0001510964
Form:       8-K
Filed at:   2022-06-01T23:59:59+00:00
Accession:  0001510964-22-000048
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

CV Sciences stockholders approve 4x share increase, reverse split up to 1:400; Board reduced to 3
--------------------------------------------------------------------------------

- Stockholders elected Dr. Joseph Maroon and Joseph Dowling as directors; 3 prior directors did not stand for re-election.
- Authorized shares increased from 200M to 800M; common stock authorized from 190M to 790M.
- Reverse stock split approved (1:10 to 1:400), at Board discretion before May 30, 2025.
- Board size reduced to 3 members to cut costs, leaving one vacancy.
- Ratification of Haskell & White as auditor for FY2022 passed; advisory vote on executive comp approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1510964/000151096422000048/0001510964-22-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1510964/000151096422000048/cvsi-20220526.htm
  HTML page:      https://secwatch.observer/filing/0001510964-22-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer